Osmotica Pharmaceuticals plc (32) | Intellectual Property (1)

Browse by Subcategory

License Agreements (1 contract)

Recent Contracts

Amendment to License Agreement, effective as of March 31, 2022, by and between RVL Pharmaceuticals, Inc. and Santen Pharmaceutical Co. Ltd (Filed With SEC on April 4, 2022)